Chadi Hage Chehade, Post-doctoral research fellow at University of Utah, shared a post by Neeraj Agarwal, Postdoctoral fellow at City of Hope, adding:
“Excited to see our work published in Clinical Cancer Research! Real-world patients with metastatic hormone-sensitive prostate cancer (mHSPC) and homologous recombination repair alterations (HRRalt) had worse survival than those with non-altered HRR. Grateful for terrific support from team.”
Title: Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Authors: Chadi Hage Chehade, Ryon P. Graf, Zeynep Irem Ozay, Georges Gebrael, Nicolas Sayegh, Gerald Li, Benjamin L. Maughan, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami
Read the Full Article.
Quoting Neeraj Agarwal‘s post:
“Just in Clinical Cancer Research. Congrats Chadi Hage Chehade, Umang Swami and GU Cancer Research Program Huntsman Cancer team. Poor outcomes w/ SOC Rx in mHSPC prostatecancer w/HRRm in 637 real-world US patients.”
